• Drug development prize bill hearings

      May 8, 2012 at 10:00 am
      Kevin Outterson

    Public hearings May 15, 2012 at Senate HELP committee. “De-linkage” proposals are an alternative to intellectual property that separate the market for R&D from the market for pills.  De-linkage has surprising support from academics, health access advocates and drug companies.

    Prior TIE coverage here.  Much more extensive materials from Jamie Love/KEI here.
    @koutterson

    Comments closed
     
      Health Policy, Law
      prize

    • by ting kwok on May 8th, 2012 at 10:25

      The reason for patent rights in the Constitution is promote science and the useful arts. Thus the patent right is NOT a natural (god-given) right. It is merely instrumental – to serve man’s interests. If we can get the same amount or more of useful invention and creativity by paying inventors & artists up front and allow production at marginal cost (i.e. without monopoly markup) then it would be more economically efficient : no Harburger Triangle 🙂

      [top]